Reaction

Acute Abdomen reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,450 reports · 25 co-occurring drugs

As of the last recalculation, Acute Abdomen appears in 1,450 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is DABIGATRAN ETEXILATE MESYLATE (PRR 14.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Dabigatran Etexilate Mesylate6914.314.3
Dabigatran Etexilate7214.014.0
Amphotericin B1112.712.7
Acetylcysteine710.710.7
Fluorouracil Cream, 0.5%5410.510.5
Fluorouracil5410.410.4
Nebivolol1110.010.0
Amlodipine Besylate And Valsartan79.19.1
Lopinavir And Ritonavir88.58.5
Oxaliplatin418.18.1
Irinotecan Hydrochloride77.87.9
Bevacizumab647.77.7
Fondaparinux Sodium47.17.1
Granisetron56.96.9
Gefitinib46.46.4
Polatuzumab Vedotin45.95.9
Tofacitinib Citrate55.55.5
Erlotinib34.54.5
Abiraterone44.24.2
Paricalcitol44.14.1
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride62.82.8
Guselkumab62.42.4
Levonorgestrel251.81.8
Tirzepatide191.71.7
Salicylic Acid51.41.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.